Get Premium to unlock powerful stock data
Viatris Inc logo

Viatris Inc

$ 11.14 +0.06 (+0.54%) 04:00 PM EST
P/E:
79.59
P/B:
0.67
Market Cap:
$ 13.51B
Enterprise V:
$ 34.70B
Volume:
8.60M
Avg Vol (2M):
13.34M
Also Trade In:
Volume:
8.60M
Market Cap $:
13.51B
PE Ratio:
79.59
Avg Vol (2-Month):
13.34M
Enterprise Value $:
34.70B
PB Ratio:
0.67
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Viatris Inc
NAICS : 325411 SIC : 2833
1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Description
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset 0.38
Debt-to-Equity 1.09
Debt-to-EBITDA 4.71
Interest Coverage 2.04
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.78
Distress
Grey
Safe
Beneish M-Score -2.81
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 76.51
9-Day RSI 65.73
14-Day RSI 58.68
6-1 Month Momentum % -22.11
12-1 Month Momentum % -31.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.22
Quick Ratio 0.82
Cash Ratio 0.11
Days Inventory 135.97
Days Sales Outstanding 78.36
Days Payable 38.28

Financials (Next Earnings Date:2022-08-09 Est.)

VTRS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:VTRS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 17,647.7
EPS (TTM) ($) 0.14
Beta 1.32
Volatility % 37.41
14-Day RSI 58.68
14-Day ATR ($) 0.40776
20-Day SMA ($) 10.4825
12-1 Month Momentum % -31.01
52-Week Range ($) 9.66 - 16.29
Shares Outstanding (Mil) 1,212.33

Piotroski F-Score Details

Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Viatris Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More